I agree that this site is using cookies. You can find further informations here.
X
Vadhavkar, Shweta
35  results:
Search for persons X
?
1

Population pharmacokinetics and CD20 binding dynamics for m..:

Bender, Brendan ; Li, Chi‐Chung ; Marchand, Mathilde...
Clinical and Translational Science.  17 (2024)  6 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
2

Early Decision Making in a Randomized Phase II Trial of Ate..:

Shemesh, Colby S. ; Chan, Phyllis ; Marchand, Mathilde...
Clinical Pharmacology & Therapeutics.  114 (2023)  3 - p. 644-651 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Pharmacokinetics and Exposure-Response Analysis of Venetocl..:

Samineni, Divya ; Gibiansky, Leonid ; Wang, Bei...
Advances in Therapy.  39 (2022)  8 - p. 3635-3653 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Extension of the Alternative Intravenous Dosing Regimens of..:

Liu, Stephanie N. ; Marchand, Mathilde ; Liu, Xiaoyan...
The Journal of Clinical Pharmacology.  62 (2022)  11 - p. 1393-1402 , 2022
Link: https://doi.org/10.1002/..
 
?
5

Phase I and scintigraphy studies to evaluate safety, tolera..:

Zhu, Rui ; Chen, Hubert ; Galanter, Joshua...
Clinical and Translational Science.  15 (2022)  5 - p. 1225-1237 , 2022
Link: https://doi.org/10.1111/..
 
?
6

Population Pharmacokinetics and Exposure‐Response Relations..:

Kotani, Naoki ; Dolton, Michael ; Svensson, Robin J....
The Journal of Clinical Pharmacology.  62 (2022)  7 - p. 905-917 , 2022
Link: https://doi.org/10.1002/..
 
?
7

Population Pharmacokinetics and Exposure-Response Relations..:

Kotani, Naoki ; Dolton, Michael ; Svensson, Robin J...
Journal of clinical pharmacology, 0091-2700, 2022, 62:7, s. 905-917.  , 2022
Link: http://urn.kb.se/resolve..
 
?
8

Phase I and scintigraphy studies to evaluate safety, tolera..:

Zhu, Rui ; Chen, Hubert ; Galanter, Joshua...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099118/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Phase I and scintigraphy studies to evaluate safety, tolera..:

Rui Zhu ; Hubert Chen ; Joshua Galanter...
https://doi.org/10.1111/cts.13240.  , 2022
Link: https://doi.org/10.1111/..
 
?
10

Pharmacokinetics and Exposure-Response Analysis of Venetocl..:

Samineni, Divya ; Gibiansky, Leonid ; Wang, Bei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309146/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Population Pharmacokinetics and Exposure‐Response Relations..:

Kotani, Naoki ; Dolton, Michael ; Svensson, Robin J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303772/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Evaluation of atezolizumab immunogenicity: Clinical pharmac..:

Benjamin Wu ; Nitzan Sternheim ; Priya Agarwal...
https://doi.org/10.1111/cts.13127.  , 2022
Link: https://doi.org/10.1111/..
 
?
13

Atezolizumab and Bevacizumab in Patients with Unresectable ..:

Shemesh, Colby S. ; Chan, Phyllis ; Shao, Hui...
Liver Cancer.  10 (2021)  5 - p. 485-499 , 2021
Link: https://doi.org/10.1159/..
 
?
14

Population repeated time‐to‐event analysis of exacerbations..:

Svensson, Robin J ; Ribbing, Jakob ; Kotani, Naoki...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  10 - p. 1221-1235 , 2021
Link: https://doi.org/10.1002/..
 
?
15

Evaluation of atezolizumab immunogenicity: Clinical pharmac..:

Wu, Benjamin ; Sternheim, Nitzan ; Agarwal, Priya...
Clinical and Translational Science.  15 (2021)  1 - p. 130-140 , 2021
Link: https://doi.org/10.1111/..
 
1-15